About TCI
TCI is a global CDMO+ partner advancing human health and well-being through science-based innovation, responsible manufacturing, and trusted global partnerships.
Our Mission
To advance human health and well-being through science-based innovation, responsible manufacturing, and trusted global partnerships.
We are committed to delivering products that are safe, effective, and designed for sustainable growth in global markets.
Sustainability & Responsibility
TCI is committed to responsible business practices that protect both people and the planet. Our sustainability initiatives include:
- Adoption of renewable energy solutions
- Resource-efficient manufacturing processes
- Long-term environmental impact reduction
We believe sustainable operations are essential to building lasting partnerships and a healthier future.
A Culture of Collaboration
Our global team brings together scientists, engineers, regulatory specialists, and commercial experts who share a commitment to excellence and innovation.
By fostering a culture of collaboration and continuous learning, we empower our people to deliver meaningful solutions for our partners worldwide.
TCI's Milestones
Discover TCI Group
TCI LIVING
Founded in 2019, TCI Living focuses on creating TCI's own brand to create the ideal life of the future by incorporating TCI's unique IBD raw materials into various types of products around the details of "clothing, food, housing and transportation". At present, we have AQUAGEN, Triple Probio and Dr.Q.
TCI GENE
TCI GENE provides consumers with a complete solution for precision medicine, including preventive testing, disease treatment and postoperative care. Through precise genetic testing, we can gain a deeper understanding of the individual's constitution and combine it with precision medicine such as cell therapy, tissue engineering and human organs to create a long-lasting and healthy future.
MBI
Founded in 1998, MBI specializes in the research and development of natural biomaterials such as collagen, hyaluronic acid and bioceramics, and was acquired by TCI in 2021. Currently, 21 implantable medical devices and a number of ODM products are available in Taiwan, China, the United States, the European Union, Korea, Southeast Asia, Russia, and Ukraine.